(Total Views: 332)
Posted On: 09/08/2020 2:56:02 PM
Post# of 36568
Re: Paul Jackson #20722
Wonderful article and I see Thomas Barnard who has written few articles Generex has a very good comment on it too..
“It is important to pursue vaccine approaches other than the unproven RNA path. The Ii-key peptide approach of NGIO/GNBT should be funded by the government with several hundred million dollars.
Instead, effective lobbyists have persuaded the government to buy the entire supply of a mediocre drug of Gilead's called remdesivir.
Thanks for your article, which brings an important vaccine platform to investor's attention.”
“It is important to pursue vaccine approaches other than the unproven RNA path. The Ii-key peptide approach of NGIO/GNBT should be funded by the government with several hundred million dollars.
Instead, effective lobbyists have persuaded the government to buy the entire supply of a mediocre drug of Gilead's called remdesivir.
Thanks for your article, which brings an important vaccine platform to investor's attention.”
(8)
(0)
